Notably, proteins such as MFGE8, LY6H, MLEC, GALNT2, and NRGN, were consistently reduced in this subgroup, even before symptom onset, underscoring their potential as early biomarkers for this distinct form of AD. This evidence concerns the gene NRGN and Alzheimer disease.